NewsBreak Original

For those of you who consume capsaicin-loaded foods, there's another positive reason for the burn — it may reduce cognitive decline in Alzheimer's disease and dementia. You heard that right, loading up your food with Scoville units might protect you against Alzheimer's disease.

Dementia is a significant global health concern with far-reaching social and economic implications. As the world's population continues to age, understanding the potential modifiable risk factors for dementia is an important consideration. The Mediterranean diet, characterized by high consumption of fruits, vegetables, whole grains, olive oil, fish, and moderate wine intake, has garnered attention for its potential protective effects against Alzheimer's disease and dementia.

Two new studies seem to show conflicting data regarding a potential link between the use of proton pump inhibitors to treat heartburn and a higher risk of dementia and Alzheimer's disease. This study adds to the ongoing discussion about these types of heartburn medications and lower cognition which can lead to dementia and Alzheimer's disease.

Vitamin D has become one of those supplements that seem to be on everyone's mind these days. I've heard all kinds of claims about the supplement, especially since the COVID-19 pandemic when there was a lot of conflicting information as to whether vitamin D could improve outcomes from the disease. Let's just say the evidence is mixed.

DAYS and B&B actress Patrika Darbo opened up about her life to two talk show pals. Patrika Darbo is beloved by daytime fans for her portrayals of Nancy on Days of our Lives and Shirley on Bold and the Beautiful. Now, the actress’s fans are sending her love and support in light of her revealing her husband’s heartbreaking medical condition.

I had written previously about a potential Alzheimer's disease vaccine that was quite exciting and potentially a "game changer" in the treatment of the disease. While researching that vaccine, I discovered several more Alzheimer's disease vaccine candidates that were at various stages of development.

Author’s note: This article is summarized from several sources and all attributions are linked within. Though there’s no guarantee that simple breathing will prevent Alzheimer’s disease, researchers from University of Southern California documented a study that had promising results. The study was small, only 108 subjects, but simple breathing and biofeedback yielded physical changes that point to a reduced risk of developing Alzheimer’s disease.

A new study shows that depression during a person's early to middle life can significantly increase the risk of dementia and Alzheimer's disease in later life. Untreated depression can lead to a lot of different outcomes (mostly bad), but knowing it can lead to a higher risk of dementia is another reason to treat it.

Columbia, South Carolina - The South Carolina Department on Aging (SCDOA) presents “Dementia 101: The Basics,” the first Wednesday of each month (August 2, 2023, and September 6, 2023). This is a free, live webinar providing education and resource information to anyone in South Carolina who wants or needs to learn about the basics of Alzheimer’s disease and other dementias.

The risk for Alzheimer's disease (AD) and severe COVID-19 appear to share a common genetic mechanism that is involved with the immune response to viruses. This does not mean that COVID-19 increases the risk for Alzheimer's disease, only that there appears to be a single genetic variant that increases the risk for both.

A lot of people are claiming that exercise improves cognition and reduces the risk of dementia or Alzheimer's disease. As usual, these types of claims are based on one study, regardless of its quality.

One of the most popular supplements for improving cognitive health, including reducing the effects of dementia, must be Ginkgo biloba. Claims about the miracle status of Ginkgo for improving your cognitive abilities and reducing the effects of dementia have been around for years.

In a groundbreaking development, researchers have unveiled a new experimental drug that offers a glimmer of hope in the fight against Alzheimer's disease. The drug, known as donanemab, has shown the potential to modestly slow the inevitable worsening of the condition by approximately four to seven months. If approved by the Food and Drug Administration, donanemab would become only the second treatment to convincingly demonstrate its efficacy in delaying the relentless progression of this mind-robbing ailment. The first FDA-approved Alzheimer's treatment, Leqembi, from Japanese pharmaceutical company Eisai, achieved this milestone recently.

We are losing our minds- literally. According to the World Health Organization (WHO), around 55 million people worldwide are living with dementia. These are staggering numbers that have a significant impact on families and communities.

The U.S. Food and Drug Administration has granted full approval for the first drug to slow down the progression of Alzheimer’s disease, opening the door for Medicare to pay for it.”This is the first medicine ever that actually changes the disease in the brain, removes a component of the disease and can extend quality of life for patients who are developing and who are in the early stages of Alzheimer’s disease,” Dr. Greg Jicha, director of clinical trials at the University of Kentucky Sanders-Brown Center on Aging, said at a news conference on Friday.

Bianca Chan, a driven and compassionate high school student from Cary, has embarked on a mission to make a difference in the lives of Alzheimer's disease patients and their caregivers. Through the NeuroLOGIC Foundation, a nonprofit organization she founded as a sophomore in high school, Chan aims to address the financial and geographical disparities that hinder access to Alzheimer's care and support services. Her dedication and innovative initiatives have already touched the lives of numerous individuals across North Carolina.

Alzheimer's is becoming more and more prevalent in our everyday lives. In fact, Neurodegenerative Disorders (NDD) such as Alzheimer's (AD), Parkinson's (PD), Dementia, and MS are very common. In 2020, 5.8 million Americans had diagnosed cases of just Alzheimer's alone, and the numbers have continued to rise. Science is proving that there are ways to delay neurodegeneration by diet, activity, nutrigenomics and epigenetics.

Dementia is a syndrome that affects memory, cognition, behavior, and the ability to perform everyday activities, with Alzheimer's disease (AD) as its most common cause. Researchers have long been fascinated by the complexities of the human brain and the biochemical processes that underpin dementia, specifically focusing on neurotransmitters, the chemical messengers of the nervous system. One such neurotransmitter, acetylcholine, has been a subject of particular interest due to its critical role in memory and cognition. Evidence shows a significant link between decreased acetylcholine levels and the onset of dementia, especially Alzheimer's disease.

The Food and Drug Administration today approved a New Drug Application (NDA) for the expanded use of Rexulti (brexpiprazole), already approved for schizophrenia, to treat agitation symptoms associated with dementia due to Alzheimer's disease (ALD).